Q2 2018

Filed Nov 14, 2018 · 10-Q · 45 days after period end · 0001740797-18-000015

Q2 2018 · 10-Q

Revenue—

Net Income

-$24.13K

no prior Q2 2017 on file

EPS Diluted

$0.00

no prior Q2 2017 on file

Gross Profit$0—

Operating Cash Flowderived-$65,916—

Same quarter

no prior Q2 2017 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Sep 30, 2018 · filed Nov 14, 2018 · 45 d after period end

Avai Bio, Inc. · CIK 1740797 · Engraved from SEC EDGAR